Nedeljko Jovanovic1, Colleen Dreyer2, Sarah Hawkins2, Kendra Thouless2, David Palma2,3, Philip C Doyle1,3,4,5, Julie A Theurer6,7,8,9. 1. Rehabilitation Sciences, Western University, London, ON, Canada. 2. London Health Sciences Centre, London, ON, Canada. 3. Lawson Health Research Institute, London, ON, Canada. 4. Department of Otolaryngology - Head and Neck Surgery, London, ON, Canada. 5. Department of Otolaryngology- Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA, USA. 6. Rehabilitation Sciences, Western University, London, ON, Canada. jtheurer@uwo.ca. 7. Lawson Health Research Institute, London, ON, Canada. jtheurer@uwo.ca. 8. Department of Otolaryngology - Head and Neck Surgery, London, ON, Canada. jtheurer@uwo.ca. 9. School of Communication Sciences and Disorders, Elborn College, Western University, London, ON, N6G 1H1, Canada. jtheurer@uwo.ca.
Abstract
PURPOSE: Patients treated for oropharyngeal cancer (OPC) are at increased risk for functional decline due to cancer-related impairments and treatment toxicities, often leading to recommendations for enteral nutritional support. This study investigated the natural history of weight and swallowing outcomes in patients with and without feeding tube (FT) placement. METHODS: Data were collected from electronic medical records of OPC patients treated with (chemo)radiotherapy at a single regional cancer center between January 2013 and December 2015. Weight measurements, Functional Oral Intake Scale (FOIS) scores, Performance Status Scale for Head and Neck Cancer (PSS-HN) normalcy of diet scores, and M.D. Anderson Dysphagia Inventory (MDADI) composite scores were gathered at baseline and at 3-, 6-, and 12-months post-treatment. Patients were grouped based on FT placement and change over time was assessed using linear mixed effects analysis. RESULTS: Of 122 eligible patients, 38 (31.1%) received a FT (FT group). Compared with baseline, weight decreased significantly at 3 and 6 months in both groups and at 12 months for patients without a FT (NFT group). Swallowing-related quality of life (QoL) decreased significantly at 3 and 6 months only in the NFT group. CONCLUSION: OPC patients experience clinically relevant decreases in weight and swallowing-related QoL in the first-year post-treatment irrespective of FT placement. These findings will contribute to improved patient monitoring and communication within the clinical setting which may ultimately lead to better outcomes for those with OPC.
PURPOSE:Patients treated for oropharyngeal cancer (OPC) are at increased risk for functional decline due to cancer-related impairments and treatment toxicities, often leading to recommendations for enteral nutritional support. This study investigated the natural history of weight and swallowing outcomes in patients with and without feeding tube (FT) placement. METHODS: Data were collected from electronic medical records of OPC patients treated with (chemo)radiotherapy at a single regional cancer center between January 2013 and December 2015. Weight measurements, Functional Oral Intake Scale (FOIS) scores, Performance Status Scale for Head and Neck Cancer (PSS-HN) normalcy of diet scores, and M.D. Anderson Dysphagia Inventory (MDADI) composite scores were gathered at baseline and at 3-, 6-, and 12-months post-treatment. Patients were grouped based on FT placement and change over time was assessed using linear mixed effects analysis. RESULTS: Of 122 eligible patients, 38 (31.1%) received a FT (FT group). Compared with baseline, weight decreased significantly at 3 and 6 months in both groups and at 12 months for patients without a FT (NFT group). Swallowing-related quality of life (QoL) decreased significantly at 3 and 6 months only in the NFT group. CONCLUSION: OPC patients experience clinically relevant decreases in weight and swallowing-related QoL in the first-year post-treatment irrespective of FT placement. These findings will contribute to improved patient monitoring and communication within the clinical setting which may ultimately lead to better outcomes for those with OPC.
Entities:
Keywords:
Chemoradiotherapy; Dysphagia; Feeding tube; Oropharyngeal cancer; Quality of life
Authors: Volker Budach; Martin Stuschke; Wilfried Budach; Michael Baumann; Dirk Geismar; Gerhard Grabenbauer; Ingrid Lammert; Klaus Jahnke; Georg Stueben; Thomas Herrmann; Michael Bamberg; Peter Wust; Wolfgang Hinkelbein; Klaus-Dieter Wernecke Journal: J Clin Oncol Date: 2005-02-20 Impact factor: 44.544
Authors: Stephanie M Shaw; Heather Flowers; Brian O'Sullivan; Andrew Hope; Louis W C Liu; Rosemary Martino Journal: Dysphagia Date: 2015-03-04 Impact factor: 3.438
Authors: E E Vokes; M S Kies; D J Haraf; K Stenson; M List; R Humerickhouse; M E Dolan; H Pelzer; L Sulzen; M E Witt; Y C Hsieh; B B Mittal; R R Weichselbaum Journal: J Clin Oncol Date: 2000-04 Impact factor: 44.544
Authors: Laura B Moroney; Jennifer Helios; Elizabeth C Ward; Jane Crombie; Leesa F Wockner; Clare L Burns; Ann-Louise Spurgin; Claire Blake; Lizbeth Kenny; Brett G M Hughes Journal: Oral Oncol Date: 2016-11-25 Impact factor: 5.337
Authors: Ryan P Goepfert; Jan S Lewin; Martha P Barrow; C David Fuller; Stephen Y Lai; Juhee Song; Brian P Hobbs; G Brandon Gunn; Beth M Beadle; David I Rosenthal; Adam S Garden; Merrill S Kies; Vali A Papadimitrakopoulou; David L Schwartz; Katherine A Hutcheson Journal: Laryngoscope Date: 2016-07-21 Impact factor: 3.325
Authors: J L Aguilar-Ponce; M Granados-García; J C Cruz López; F Maldonado-Magos; M A Alvarez-Avitia; O Arrieta; I González-Ramírez; G Lara-Cruz; I Martinez-Juárez; R Medina-Santillan; C Castillo-Hernández; J De la Garza-Salazar Journal: Oral Oncol Date: 2012-10-06 Impact factor: 5.337
Authors: D M Brizel; M E Albers; S R Fisher; R L Scher; W J Richtsmeier; V Hars; S L George; A T Huang; L R Prosnitz Journal: N Engl J Med Date: 1998-06-18 Impact factor: 91.245
Authors: David J Adelstein; Yi Li; George L Adams; Henry Wagner; Julie A Kish; John F Ensley; David E Schuller; Arlene A Forastiere Journal: J Clin Oncol Date: 2003-01-01 Impact factor: 44.544